Evidence map›Paper›PMID 40585819›Full record

ArticleWorld journal of clinical oncology2025

Predictors of survival in gastric mucosa-associated lymphoid tissue lymphoma: An updated surveillance, epidemiology, and end results-based analysis of age and gender disparities.

Ayrton I Bangolo, Khaled Sharaan, Behzad Amoozgar, Shruti Wadhwani, Lili Zhang, Nikita Wadhwani, Vignesh K Nagesh, Jay Mehta, Rishabh Goyal, Gia DeRose and 9 more

Abstract read
In one paragraph

Article in World journal of clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ayrton I BangoloDepartment of Hematology and Oncology, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ 07601, United States. ayrtonbangolo@yahoo.com.
Khaled SharaanDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Behzad AmoozgarDepartment of Hematology and Oncology, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ 07601, United States.
Shruti WadhwaniDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Lili ZhangDepartment of Hematology and Oncology, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ 07601, United States.
Nikita WadhwaniDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Vignesh K NageshDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Jay MehtaDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Rishabh GoyalDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Gia DeRoseDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Sarvarinder GillDepartment of Hematology and Oncology, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ 07601, United States.
Courtney ChristoforoDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Swapnika MallipeddiDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Selbin BobanDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Shubham MadanDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Budoor AlqinaiDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Timophyll Yh FongDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Simcha WeissmanDepartment of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ 07047, United States.
Pierre FweloDepartment of Epidemiology, Human Genetics, and Environmental Sciences, UTHealth School of Public Health, Houston, TX 77030, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMucosa-associated lymphoid tissue (MALT) lymphoma is a subtype of extranodal marginal zone lymphoma, typically occurring in mucosal sites such as the stomach, salivary glands, and lungs. This study aims to analyze the demographic and clinicopathologic characteristics of patients with gastric MALT lymphoma in the United States and evaluate the interaction between age and gender on survival outcomes.

aimTo analyze the demographic and clinicopathologic characteristics of patients with gastric MALT lymphoma in the United States and evaluate the interaction between age and gender on survival outcomes.

methodsA retrospective cohort study was conducted using the Surveillance, Epidemiology, and End Results (SEER) database, which included 2453 patients diagnosed with MALT lymphoma from 2010 to 2021. Data were analyzed for demographic factors, tumor characteristics, treatment modalities, and survival outcomes. A Cox proportional hazards regression model was used to identify predictors of overall mortality and cancer-specific mortality.

resultsThe study predominantly included Non-Hispanic White patients (62.78%), with nearly equal gender distribution (50.31% females, 49.69% males), and most diagnoses occurring in individuals aged 60-79 years. The majority of tumors were localized (80.07%). Multivariate analysis identified older age, male gender, advanced tumor stage, and socioeconomic factors-such as annual income and marital status-as independent predictors of mortality. No significant interaction between age and gender on mortality outcomes was observed.

conclusionSociodemographic factors, including advanced age, male gender, annual income, and marital status, as well as advanced tumor stage, significantly impacted survival outcomes in patients with MALT lymphoma. Radiotherapy was associated with a reduction in overall mortality. Early detection is crucial for optimizing outcomes, as localized disease responds well to available treatment modalities.

Indexed as

Extranodal marginal zone lymphomaGastrointestinal cancerMortalityMucosa-associated lymphoid tissue lymphoma

Identifiers

PMID40585819
PMCPMC12198866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.